<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cell Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Cell. Mol. Med</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1582-4934</journal-id>
<journal-id journal-id-type="publisher-id">JCMM</journal-id>
<journal-title-group>
<journal-title>Journal of Cellular and Molecular Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1582-1838</issn>
<issn pub-type="epub">1582-4934</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28272772</article-id>
<article-id pub-id-type="pmc">5571513</article-id>
<article-id pub-id-type="doi">10.1111/jcmm.13128</article-id>
<article-id pub-id-type="publisher-id">JCMM13128</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<styled-content style="fixed-case">TUSC</styled-content>3: a novel tumour suppressor gene and its functional implications</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="jcmm13128-cr-0001">
<name>
<surname>Yu</surname>
<given-names>Xinshuang</given-names>
</name>
<xref ref-type="aff" rid="jcmm13128-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13128-cr-0002">
<name>
<surname>Zhai</surname>
<given-names>Chunjuan</given-names>
</name>
<xref ref-type="aff" rid="jcmm13128-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13128-cr-0003">
<name>
<surname>Fan</surname>
<given-names>Yujun</given-names>
</name>
<xref ref-type="aff" rid="jcmm13128-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13128-cr-0004">
<name>
<surname>Zhang</surname>
<given-names>Jiandong</given-names>
</name>
<xref ref-type="aff" rid="jcmm13128-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13128-cr-0005">
<name>
<surname>Liang</surname>
<given-names>Ning</given-names>
</name>
<xref ref-type="aff" rid="jcmm13128-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13128-cr-0006">
<name>
<surname>Liu</surname>
<given-names>Fengjun</given-names>
</name>
<xref ref-type="aff" rid="jcmm13128-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13128-cr-0007">
<name>
<surname>Cao</surname>
<given-names>Lili</given-names>
</name>
<xref ref-type="aff" rid="jcmm13128-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13128-cr-0008">
<name>
<surname>Wang</surname>
<given-names>Jia</given-names>
</name>
<xref ref-type="aff" rid="jcmm13128-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="jcmm13128-cr-0009">
<name>
<surname>Du</surname>
<given-names>Juan</given-names>
</name>
<address>
<email>sunnydujuan@aliyun.com</email>
</address>
<xref ref-type="aff" rid="jcmm13128-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="jcmm13128-aff-0004">
<sup>4</sup>
</xref>
</contrib>
</contrib-group>
<aff id="jcmm13128-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Radiation Oncology</named-content>
<named-content content-type="organisation-division">Shandong Provincial Qianfoshan Hospital</named-content>
<institution>Shandong University</institution>
<named-content content-type="city">Jinan</named-content>
<country country="CN">China</country>
</aff>
<aff id="jcmm13128-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Cardiology</named-content>
<named-content content-type="organisation-division">Shandong Provincial Hospital affiliated to Shandong University</named-content>
<institution>Shandong University</institution>
<named-content content-type="city">Jinan</named-content>
<country country="CN">China</country>
</aff>
<aff id="jcmm13128-aff-0003">
<label><sup>3</sup></label>
<institution>Medical Management Service Center of Shandong Provincial Health and Family Planning Commission</institution>
<named-content content-type="city">Jinan</named-content>
<country country="CN">China</country>
</aff>
<aff id="jcmm13128-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Medical Research Center</named-content>
<named-content content-type="organisation-division">Shandong Provincial Qianfoshan Hospital</named-content>
<institution>Shandong University</institution>
<named-content content-type="city">Jinan</named-content>
<country country="CN">China</country>
</aff>
<aff id="jcmm13128-aff-0005">
<label><sup>5</sup></label>
<institution>China Institute of Veterinary Drugs Control</institution>
<named-content content-type="city">Beijing</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>
Correspondence to: Juan Du<break></break>
E‐mail: <email>sunnydujuan@aliyun.com</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2017</year>
</pub-date>
<volume>21</volume>
<issue>9</issue>
<issue-id pub-id-type="doi">10.1111/jcmm.2017.21.issue-9</issue-id>
<fpage>1711</fpage>
<lpage>1718</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>1</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:JCMM-21-1711.pdf" xlink:type="simple"></self-uri>
<abstract id="jcmm13128-abs-0001">
<title>Abstract</title>
<p>The tumour suppressor candidate 3 (<styled-content style="fixed-case">TUSC</styled-content>3) gene is located on chromosome region 8p22 and encodes the 34 kD <styled-content style="fixed-case">TUSC</styled-content>3 protein, which is a subunit of the oligosaccharyl transferase responsible for the <italic>N</italic>‐glycosylation of nascent proteins. Known to be related to autosomal recessive mental retardation for several years, <styled-content style="fixed-case">TUSC</styled-content>3 has only recently been identified as a potential tumour suppressor gene. Based on the structure and function of <styled-content style="fixed-case">TUSC</styled-content>3, specific mechanisms in various diseases have been investigated. Several studies have demonstrated that <styled-content style="fixed-case">TUSC</styled-content>3 is an Mg<sup>2+</sup>‐transporter involved in magnesium transport and homeostasis, which is important for learning and memory, embryonic development and testis maturation. Moreover, dysfunction or deletion of <styled-content style="fixed-case">TUSC</styled-content>3 exerts its oncological effects as a modulator by inhibiting glycosylation efficiency and consequently inducing endoplasmic reticulum stress and malignant cell transformation. In this study, we summarize the advances in the studies of <styled-content style="fixed-case">TUSC</styled-content>3 and comment on the potential roles of <styled-content style="fixed-case">TUSC</styled-content>3 in diagnosis and treatment of <styled-content style="fixed-case">TUSC</styled-content>3‐related diseases, especially cancer.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="jcmm13128-kwd-0001">tumour suppressor candidate 3</kwd>
<kwd id="jcmm13128-kwd-0002">oligosaccharyl transferase</kwd>
<kwd id="jcmm13128-kwd-0003">tumourgenesis</kwd>
<kwd id="jcmm13128-kwd-0004"><italic>N</italic>‐glycosylation reaction</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Medical and Health Science and Technology Development Plan of Shandong Province</funding-source>
<award-id>2015WSB04012</award-id>
<award-id>2015WS0213</award-id>
</award-group>
<award-group>
<funding-source>Natural Science Foundation of Shandong Province</funding-source>
<award-id>ZR2011HQ010</award-id>
<award-id>ZR2016HQ50</award-id>
<award-id>ZR2015HM077</award-id>
</award-group>
<award-group>
<funding-source>National Natural Science Foundation of China</funding-source>
<award-id>30901712</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="2"></table-count>
<page-count count="8"></page-count>
<word-count count="5606"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>jcmm13128</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>September 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.8 mode:remove_FC converted:25.08.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="jcmm13128-sec-0001">
<title>Introduction</title>
<p>Tumour suppressor candidate 3 (TUSC3) was first identified on human chromosomes 8p22 by MacGrogan in 1996 <xref ref-type="ref" rid="jcmm13128-bib-0001">1</xref>. It was found that the gene is highly expressed in a variety of epithelial cells and tissues including prostate, colon, lung, liver <xref ref-type="ref" rid="jcmm13128-bib-0001">1</xref>, ovary, placenta, testis and adipose tissues <xref ref-type="ref" rid="jcmm13128-bib-0002">2</xref>, but is rarely expressed in other tissues. Upon closer examination, more and more functions of TUSC3 have been discovered. TUSC3 interacts with the protein phosphatase 1 (PPPC1A) and affects the magnesium ion (Mg<sup>2+</sup>) transport system, which plays an important role in learning and memory <xref ref-type="ref" rid="jcmm13128-bib-0003">3</xref>. Therefore, the deletion or mutation of TUSC3 may be associated with non‐syndromic autosomal recessive mental retardation (ARMR) <xref ref-type="ref" rid="jcmm13128-bib-0004">4</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0005">5</xref>. Required for cellular magnesium uptake, TUSC3 has been proven to be a pivotal molecule in embryonic development <xref ref-type="ref" rid="jcmm13128-bib-0002">2</xref>. Notably, TUSC3 has been identified as a potential tumour suppressor gene and is closely related to the malignant transformation of cells <xref ref-type="ref" rid="jcmm13128-bib-0003">3</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0006">6</xref>. TUSC3 shares high sequence homology with Ost3p, a subunit of the oligosaccharyl transferase (OST) complex and is involved in the <italic>N</italic>‐glycosylation reaction of the protein folding process <xref ref-type="ref" rid="jcmm13128-bib-0007">7</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0008">8</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0009">9</xref>. The deletion or mutation of TUSC3 in cells may induce the accumulation of unfolding proteins and in turn the cells may suffer carcinogenesis <xref ref-type="ref" rid="jcmm13128-bib-0010">10</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0011">11</xref>. In this review, we focus on recent results related to TUSC3's role in varied diseases and discuss the potential applications of TUSC3 in ‘TUSC3‐related diseases’, especially in cancers.</p>
</sec>
<sec id="jcmm13128-sec-0003">
<title>The structure of the TUSC3 gene and protein</title>
<p>TUSC3 (GenBank accession No. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="AI366810">AI366810</ext-link>), also named as N33, M33, MRT7, MRT22, OST3A and D8S1992, is located on chromosome 8p22 <xref ref-type="ref" rid="jcmm13128-bib-0012">12</xref>. Chromosome 8 is a typical chromosome with respect to size (146.364 Mb), number of genes (1198), repeat content and degree of segmental duplication <xref ref-type="ref" rid="jcmm13128-bib-0013">13</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0014">14</xref>. However, its p arm is a region with high frequent allelic loss and homozygous deletion <xref ref-type="ref" rid="jcmm13128-bib-0014">14</xref>. Recently, this region has been called an ‘anchor port’ contributing to cancer development through genomic alteration. It isthought to be a chromosomal region of frequent genetic loss <xref ref-type="ref" rid="jcmm13128-bib-0015">15</xref>.</p>
<p>TUSC3 gene is comprised of 11 exons spanning 349,435 bp of the genomic DNA on chromosome 8p22 (Fig. <xref ref-type="fig" rid="jcmm13128-fig-0001">1</xref>) <xref ref-type="ref" rid="jcmm13128-bib-0003">3</xref>. Two transcript variants encoding distinct isoforms have been identified for this gene (provided by RefSeq, Jul 2008). According to the UniProtKB database, TUSC3 encodes a predicted protein with 348 amino acid protein, including an N‐terminal region with 170 residues and four trans‐membrane regions. The TUSC3 protein is localized in the endoplasmic reticulum and is a subunit of the endoplasmic reticulum‐bound OST complex (Fig. <xref ref-type="fig" rid="jcmm13128-fig-0002">2</xref>), which is primarily responsible for protein N‐linked glycosylation catalysing the transfer of a 14‐sugar oligosaccharide from dolichol to nascent proteins during the process of protein maturity <xref ref-type="ref" rid="jcmm13128-bib-0004">4</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0007">7</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0008">8</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0016">16</xref>. The human OST complex is a hetero‐oligomer of seven subunits <xref ref-type="ref" rid="jcmm13128-bib-0008">8</xref> and consists of the subunits ribophorin I, ribophorin II, OST48, Ost4, DAD1, Stt3A or Stt3B and TUSC3/N33orIAP/MagT1 (Fig. <xref ref-type="fig" rid="jcmm13128-fig-0002">2</xref>) <xref ref-type="ref" rid="jcmm13128-bib-0016">16</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0017">17</xref>. TUSC3 is believed to be the ortholog of the yeast Ost3p which is initially identified as a 34 kD subunit in the yeast oligosaccharyltransferase (OST) complex <xref ref-type="ref" rid="jcmm13128-bib-0018">18</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0019">19</xref>. Two proteins share about 20% sequence identity, and both contain an N‐terminal active binding domain, central acidic and zinc‐binding domains, and a C‐terminal trans‐membrane domain <xref ref-type="ref" rid="jcmm13128-bib-0008">8</xref>. Its trans‐membrane segments and an N‐terminal signal peptide are particularly well conserved <xref ref-type="ref" rid="jcmm13128-bib-0016">16</xref>.</p>
<fig fig-type="Figure" id="jcmm13128-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>The <styled-content style="fixed-case">TUSC</styled-content>3 gene locus.</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="JCMM-21-1711-g001"></graphic>
</fig>
<fig fig-type="Figure" id="jcmm13128-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>The structure of the oligosaccharyl transferase (<styled-content style="fixed-case">OST</styled-content>) complex. <styled-content style="fixed-case">ER</styled-content> Lumen, endoplasmic reticulum lumen.</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="JCMM-21-1711-g002"></graphic>
</fig>
<p>TUSC3 has two splicing variants that differ at their C‐terminal only in the last five residues <xref ref-type="ref" rid="jcmm13128-bib-0002">2</xref>. TUSC3‐1 co‐sedimented with the active OST complex, but TUSC3‐2 dissociated from the OST complex during membrane solubilization, and is most likely weakly associated with the active complex <xref ref-type="ref" rid="jcmm13128-bib-0020">20</xref>.</p>
<p>The subunits TUSC3 anchors to the ER membrane <italic>via</italic> C‐terminal trans‐membrane domains possesses its N‐terminal domains in the endoplasmic reticulum (ER) lumen, which includes a characteristic Cys‐Xaa‐Xaa‐Cys motif harbouring the active‐site cysteine pair <xref ref-type="ref" rid="jcmm13128-bib-0008">8</xref>. In normal cells, TUSC3 proteins have the capability of forming oligomers. It can delay oxidative substrate folding through mixed disulfide formation and increase the probability of sequon recognition and glycosylation by the catalytic subunit Stt3A/B as a nascent polypeptide chain passes the OST complex during co‐translational translocation <xref ref-type="ref" rid="jcmm13128-bib-0008">8</xref>. The unpaired cysteine residues of human glycoproteins have the potential to regulate glycosylation efficiency through transient interaction with TUSC3.</p>
<p>The similarities in primary and secondary structure between TUSC3 and yeast Ost3p suggest the existence of OST regulatory subunits in vertebrate cells <xref ref-type="ref" rid="jcmm13128-bib-0001">1</xref>. TUSC3 action in the regulation of <italic>N</italic>‐glycosylation is linked with its sequence‐specific interaction with polypeptide segments of glycoproteins. The glycan transfer process is a highly conserved process in eukaryocyte <xref ref-type="ref" rid="jcmm13128-bib-0017">17</xref>. Glycosylation is an important post‐translational modification in eukaryotic cells and has a significant impact on numerous biological processes <xref ref-type="ref" rid="jcmm13128-bib-0021">21</xref>. As N‐linked glycosylation of proteins is an indispensable modification for the correct folding of glycoprotein and onward transportation of newly synthesized proteins, the dysfunction or deletion of TUSC3 exerts its pathogenic effect as a modulator of glycosylation reaction in a variety of diseases, especially in tumours <xref ref-type="ref" rid="jcmm13128-bib-0017">17</xref> .</p>
</sec>
<sec id="jcmm13128-sec-0004">
<title>The relationship between TUSC3 and diseases</title>
<sec id="jcmm13128-sec-0005">
<title>Role of TUSC3 in maintaining normal function of the central nervous system</title>
<p>Many genomic imbalances on the 8p locus are associated with learning disabilities and have been touted as a ‘hub’ for neuropsychiatric developmental disorders <xref ref-type="ref" rid="jcmm13128-bib-0022">22</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0023">23</xref>. The localization and structure of TUSC3 (located on 8p22) implies that it might be involved in the development and differentiation of the nervous system.</p>
<p>Early in 2008, Garshasbi <xref ref-type="ref" rid="jcmm13128-bib-0004">4</xref> investigated seven patients with non‐syndromic ARMR in four sibling relationships. They found that the homozygous deletion caused a complete loss of TUSC3 function and was responsible for the observed non‐syndromic mental retardation (MR) phenotype. Then in 2011, Garshasbi <xref ref-type="ref" rid="jcmm13128-bib-0005">5</xref> also found that independent mutations of TUSC3 cause a non‐specific form of severe ARMR. Khan <xref ref-type="ref" rid="jcmm13128-bib-0013">13</xref> reported a novel mutation involving the deletion of the entire TUSC3 gene (except for the promoter and first exon) in a consanguineous Pakistani family with autosomal recessive non‐syndromic intellectual disability.</p>
<p>The above results suggest that TUSC3 plays an important role in maintaining normal function in the central nervous system. TUSC3 has proven to express ubiquitously in the foetal brain <xref ref-type="ref" rid="jcmm13128-bib-0007">7</xref> and interact with the alpha isoform of the protein phosphatase 1 (PPPC1A) catalytic subunit, which is involved in the modulation of synaptic plasticity and in the memory and learning processes in mice <xref ref-type="ref" rid="jcmm13128-bib-0004">4</xref>. Other studies <xref ref-type="ref" rid="jcmm13128-bib-0002">2</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0024">24</xref> reveal that TUSC3 is also an Mg<sup>2+</sup>‐transporter involved in magnesium transport and is involved in magnesium homeostasis. Intracellular magnesium is abundant and plays an important role in biochemical functions and morphological and cytological changes <xref ref-type="ref" rid="jcmm13128-bib-0024">24</xref>. In fact, it has been demonstrated that TUSC3 is an indispensable member of the vertebrate plasma membrane magnesium ion (Mg<sup>2+</sup>) transport system <xref ref-type="ref" rid="jcmm13128-bib-0002">2</xref> and the latest research results show that increasing Mg<sup>2+</sup> level in the brain leads to an enhancement of learning abilities, working memory, and short‐and long‐term memory in rats <xref ref-type="ref" rid="jcmm13128-bib-0025">25</xref>.</p>
<p>Together, TUSC3 interacts with the alpha isoform of the protein phosphatase1 <xref ref-type="ref" rid="jcmm13128-bib-0026">26</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0027">27</xref> and works with the magnesium ion transport system, which plays an important role in learning and memory <xref ref-type="ref" rid="jcmm13128-bib-0003">3</xref> (Fig. <xref ref-type="fig" rid="jcmm13128-fig-0003">3</xref>A and B). It could be assumed that disturbed Mg<sup>2+</sup> levels attributed to TUSC3 impairment were responsible for the MR phenotype observed in patients <xref ref-type="ref" rid="jcmm13128-bib-0005">5</xref>. Deficiency of human N33/Tusc3 results in isolated cognitive defects <xref ref-type="ref" rid="jcmm13128-bib-0004">4</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0007">7</xref>. Further research on the functions of TUSC3 will provide significant insights into neuropsychiatric developmental disorders. Therefore, TUSC3 may be used as a helpful biomarker in the diagnosis of ARMR and as a therapeutic target for clinical treatment of ARMR in the future.</p>
<fig fig-type="Figure" id="jcmm13128-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>
<styled-content style="fixed-case">TUSC</styled-content>3 gene dysfunction in related to different diseases. (<bold>A</bold>) <styled-content style="fixed-case">TUSC</styled-content>3 gene dysfunction in related to <styled-content style="fixed-case">ARMR</styled-content> or <styled-content style="fixed-case">NSID</styled-content>. Dysfunctional <styled-content style="fixed-case">TUSC</styled-content>3 cannot interact with the alpha isoform of the protein phosphatase 1 (<styled-content style="fixed-case">PPPC</styled-content>1A) catalytic subunit. Thereafter, the synaptic plasticity of neuron is impaired and in fact the memory and learning processes will be damaged. Consequently, the <styled-content style="fixed-case">ARMR</styled-content> or <styled-content style="fixed-case">NSID</styled-content> would occur. (<bold>B</bold>) <styled-content style="fixed-case">TUSC</styled-content>3 gene dysfunction in related to <styled-content style="fixed-case">ARMR</styled-content> or <styled-content style="fixed-case">NSID</styled-content>. <styled-content style="fixed-case">TUSC</styled-content>3 is an indispensable member of the vertebrate plasma membrane magnesium ion (Mg<sup>2+</sup>) transport system. Decreasing Mg<sup>2+</sup> level in the brain leads to an impairment of learning abilities, working memory, and short‐and long‐term memory. Consequently, the <styled-content style="fixed-case">ARMR</styled-content> or <styled-content style="fixed-case">NSID</styled-content> would occur. (<bold>C</bold>) <styled-content style="fixed-case">TUSC</styled-content>3 gene dysfunction in association with <italic>N</italic>‐glycosylation of proteins &amp; Tumourigenesis. <styled-content style="fixed-case">TUSC</styled-content>3 is a subunit of oligosaccharyl transferase (<styled-content style="fixed-case">OST</styled-content>) complex which is responsible for protein N‐linked glycosylation catalysing the transfer of a 14‐sugar oligosaccharide from dolichol to nascent proteins during the process of protein maturity. <styled-content style="fixed-case">TUSC</styled-content>3 disfunction induced the improper glycosylation and perturbation in protein folding, which in turn may induce alterations in endoplasmic reticulum structure and function, termed <styled-content style="fixed-case">ER</styled-content> stress, and consequently result in malignant cell transformation. (<styled-content style="fixed-case">ARMR</styled-content>), nonsyndromic autosomal recessive mental retardation; <styled-content style="fixed-case">NSID</styled-content>, nonsyndromic intellectual disability; <styled-content style="fixed-case">ER</styled-content>, endoplasmic reticulum.</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="JCMM-21-1711-g003"></graphic>
</fig>
</sec>
<sec id="jcmm13128-sec-0006">
<title>Role of TUSC3 in maintaining normal function in embryonic development</title>
<p>Hao Zhou and David E. Clapham found that TUSC3 is engaged in embryonic development <italic>via</italic> interfering with cellular Mg<sup>2+</sup> uptake <xref ref-type="ref" rid="jcmm13128-bib-0002">2</xref>. Studies <xref ref-type="ref" rid="jcmm13128-bib-0002">2</xref> have proven that TUSC3 is indispensable to members with mammalian cellular Mg<sup>2+</sup> uptake and is crucial for embryonic development in zebrafish. Reduction or deletion of TUSC3 expression in zebrafish embryos results in the early developmental arrest.</p>
<p>TUSC3 is also involved in spermatogenesis in the testis and is associated with sperm differentiation and maturation <xref ref-type="ref" rid="jcmm13128-bib-0024">24</xref>. Mg<sup>2+</sup>plays an important role in spermatogenesis, as magnesium administration can increases androgenic enzyme activity, which is crucial for spermatogenesis <xref ref-type="ref" rid="jcmm13128-bib-0028">28</xref>. As we know, sperm carries genetic cargo, which is necessary for systematic germ cell development and maturation. TUSC3 is upregulated during sexual maturation in the testis. Khalid <italic>et al</italic>. <xref ref-type="ref" rid="jcmm13128-bib-0024">24</xref> demonstrated that TUSC3 was stronger in spermatocytes than spermatids. The TUSC3 gene participated in spermatogenesis <italic>via</italic> modulating the serum testosterone concentration, which is irradiated by modulating intracellular Mg<sup>2+</sup> concentration.</p>
<p>However, the evidence that TUSC3 has influenced the embryo development and spermatogenesis is still inadequate. A deeper understanding of TUSC3's role in embryonic development and spermatogenesis requires further exploration.</p>
</sec>
<sec id="jcmm13128-sec-0007">
<title>Role of TUSC3 as a tumour suppressor gene</title>
<p>Accumulated data have established a strong link between TUSC3 and cancer. It has already been proven that TUSC3 is either lost or reduced in several cancers, including prostate, ovarian, gastric, pancreatic cancer and osteosarcoma <xref ref-type="ref" rid="jcmm13128-bib-0001">1</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0024">24</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0029">29</xref>.</p>
<p>Early in 2005, Pils <xref ref-type="ref" rid="jcmm13128-bib-0030">30</xref> reported that expression of TUSC3 was lower only in tumours of advanced grade (significant), FIGO (the International Federation of Obstetricians and Gynecologists) stages and in patients with relapse (trends not significant). This indicates that TUSC3 is correlated with cancer stage and invasive potential to some extent. Pils <xref ref-type="ref" rid="jcmm13128-bib-0006">6</xref> proved that TUSC3 hypermethylation correlates with the survival of patients, indicating that TUSC3 is an accepted marker of poor prognosis in ovarian cancer patients. Moreover, another study <xref ref-type="ref" rid="jcmm13128-bib-0031">31</xref> demonstrated that TUSC3 methylation level in blood leukocyte DNA was higher in gastric cancer patients than in the healthy controls, though with no statistic difference. Ribeiro <xref ref-type="ref" rid="jcmm13128-bib-0032">32</xref> found that loss of TUSC3 gene may serve as a good indicator of malignancy in oral squamous cell carcinoma. TUSC3 gene played an important role in the transition from normal oral mucosa to potentially malignant oral mucosa. Loss of TUSC3 (8p22) is correlated with the advanced stage and lymph node metastasis and poor survival in larynx and pharynx squamous cell carcinoma <xref ref-type="ref" rid="jcmm13128-bib-0033">33</xref>. Our observations demonstrated that the TUSC3 expressions in normal controls were significantly higher than those in small‐cell lung cancer (SCLC) patients. Additionally, a marked decrease of TUSC3 expressions in patients with Lymph node metastasis positive (LNM<sup>+</sup>) was identified compared with patients with Lymph node metastasis negative (LNM<sup>−</sup>). Our results indicated that TUSC3 expressions may be a useful predictor of lymph node metastasis in SCLC cancer patients (Data not shown). The most significant cancer‐associated function of TUSC3 is associated with the vital role of OST catalysing in the protein <italic>N</italic>‐glycosylation process, which is tightly linked to the proper folding of nascent peptides shuttling and quality control <xref ref-type="ref" rid="jcmm13128-bib-0004">4</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0016">16</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0018">18</xref>.</p>
<p>
<italic>N</italic>‐glycosylation of proteins <xref ref-type="ref" rid="jcmm13128-bib-0018">18</xref> in the ER is a complex process and is crucial to ensure correct folding of newly synthesized proteins carried out by OST complex <xref ref-type="ref" rid="jcmm13128-bib-0004">4</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0016">16</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0034">34</xref>. It is well established that abnormal <italic>N</italic>‐glycosylation of proteins is associated with cancer development and progression <xref ref-type="ref" rid="jcmm13128-bib-0035">35</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0036">36</xref>.</p>
<p>Perturbations in protein folding by improper glycosylation may induce alterations in endoplasmic reticulum structure and function, termed ER stress, and consequently result in malignant cell transformation (Fig. <xref ref-type="fig" rid="jcmm13128-fig-0003">3</xref>C) <xref ref-type="ref" rid="jcmm13128-bib-0017">17</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0021">21</xref>.</p>
<p>Kratochvilova <italic>et al</italic>. <xref ref-type="ref" rid="jcmm13128-bib-0011">11</xref> have reported that TUSC3 linked distinct biological mechanisms regulating the ER stress response and the EMT (Epithelial‐Mesenchymal Transition) <italic>in vitro</italic>, and promoting tumour growth <italic>in vivo</italic>. Vaňhara <italic>et al</italic>. <xref ref-type="ref" rid="jcmm13128-bib-0021">21</xref> identified that loss of the TUSC3 promoted proliferation and migration of ovarian cancer cells through affecting the <italic>N</italic>‐glycosylating events in ovarian cancer. Peter Horak found that TUSC3 loss increased <italic>N</italic>‐glycosylation of cell surface proteins and alleviates endoplasmic reticulum stress in prostate cancer cells <xref ref-type="ref" rid="jcmm13128-bib-0010">10</xref>.</p>
<p>The precise molecular mechanism through which TUSC3 is involved in the development of cancer remains unclear. Some results demonstrate that TUSC3 is an ER integral protein involved in <italic>N</italic>‐glycosylation <xref ref-type="ref" rid="jcmm13128-bib-0021">21</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0037">37</xref>. Previous studies have indicated that <italic>N</italic>‐glycosylation abnormalities affect the growth of tumour cells by affecting the PI3K‐Akt pathway <xref ref-type="ref" rid="jcmm13128-bib-0038">38</xref>. Perhaps there are other pathways remaining to be found.</p>
</sec>
</sec>
<sec id="jcmm13128-sec-0008">
<title>Mechanisms for TUSC3 gene dysfunction</title>
<p>Frequently deletion, mutation and promoter hypermethylation are common mechanisms for gene dysfunction <xref ref-type="ref" rid="jcmm13128-bib-0039">39</xref>. The dysfunction of TUSC3 was also commonly because of the genetic and epigenetics alterations <xref ref-type="ref" rid="jcmm13128-bib-0006">6</xref>.</p>
<sec id="jcmm13128-sec-0009">
<title>Genetic alteration of TUSC3</title>
<p>TUSC3 was first cloned from a homozygous deletion in a metastatic prostate carcinoma <xref ref-type="ref" rid="jcmm13128-bib-0040">40</xref>. Homozygous deletions of the TUSC3 gene have been revealed <italic>in vitro</italic> experiments on human prostate, lung, liver and colon cell lines, as well as lymph node tumour, breast and pancreatic cancer <xref ref-type="ref" rid="jcmm13128-bib-0024">24</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0039">39</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0041">41</xref>. Loddo <xref ref-type="ref" rid="jcmm13128-bib-0042">42</xref> reported on a boy affected by ‘syndromic’ ID (Intellectual Disability) with a homozygous micro‐deletion in 8p22, encompassing the first exon of TUSC3 in which the alteration consists of an intragenic deletion. Ghadami <xref ref-type="ref" rid="jcmm13128-bib-0043">43</xref> also found a high percentage of homozygous deletions of TUSC3 in the Iranian population. Homozygous loss and homozygous mutations of TUSC3 occur mostly in the family tree of close relatives <xref ref-type="ref" rid="jcmm13128-bib-0013">13</xref>. Aberrant TUSC3 reduction in many cancers was detected. The sites of the deletions mutation was identified within exon 1 region <xref ref-type="ref" rid="jcmm13128-bib-0014">14</xref> and nonsense mutation was within exon 2 region <xref ref-type="ref" rid="jcmm13128-bib-0005">5</xref>.</p>
<p>Frequently, loss of heterozygosity of TUSC3 was found in several diseases. Sleptsov <xref ref-type="ref" rid="jcmm13128-bib-0044">44</xref> demonstrated the heterozygosity loss of TUSC3 in vascular tissues and peripheral blood leukocytes from patients with atherosclerosis. TUSC3 has already been suggested as an important target of genomic rearrangements in epithelial cancers <xref ref-type="ref" rid="jcmm13128-bib-0045">45</xref>. Copy‐number variation involving TUSC3 has also been described in a parent and child from the Hap Map project <xref ref-type="ref" rid="jcmm13128-bib-0046">46</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0047">47</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0048">48</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0049">49</xref>. Alternative splicing is an important component of tumourigenesis with indication of known alternative splicing in TUSC3 <xref ref-type="ref" rid="jcmm13128-bib-0050">50</xref>. Additionally, the TUSC3 gene single nucleotide polymorphism was found in patients with non‐syndromic MR <xref ref-type="ref" rid="jcmm13128-bib-0003">3</xref>. Major mutations/deletions reported to date as pertaining to different diseases/cancer are illustrated in Table <xref ref-type="table-wrap" rid="jcmm13128-tbl-0001">1</xref>.</p>
<table-wrap id="jcmm13128-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>The mutation patterns found in TUSC3 in diseases/cancers</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Diseases</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mutation patterns</th>
<th align="left" colspan="1" rowspan="1" valign="top">TUSC3 functions and clinical significance</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">Homozygous deletion</td>
<td align="left" colspan="1" rowspan="1">A defect in the TUSC3 gene is associated with NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">Nonsense mutation (c.163C&gt;T [p.Q55X])</td>
<td align="left" colspan="1" rowspan="1">TUSC3 mutations cause an non‐specific form of severe mental retardation</td>
<td align="left" colspan="1" rowspan="1">5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">Missense mutation (c.932T/G, p.V311G)</td>
<td align="left" colspan="1" rowspan="1">TUSC3 mutation is associated with NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">Homozygous deletion</td>
<td align="left" colspan="1" rowspan="1">A novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family with NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">Homozygous aberrant transcript at Exon 7</td>
<td align="left" colspan="1" rowspan="1">Homozygous Truncating Intragenic Duplication in TUSC3 Responsible for NS‐ARMR</td>
<td align="left" colspan="1" rowspan="1">38</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Prostate cancer</td>
<td align="left" colspan="1" rowspan="1">NM</td>
<td align="left" colspan="1" rowspan="1">Loss of TUSC3 expression in prostate cancer cell lines leads to increased proliferation, migration and invasion as well as accelerated xenograft growth.</td>
<td align="left" colspan="1" rowspan="1">10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ovarian cancer cells</td>
<td align="left" colspan="1" rowspan="1">Loss of TUSC3 (NM)</td>
<td align="left" colspan="1" rowspan="1">Loss of TUSC3 enhances proliferation and migration of ovarian cancer cells <italic>in vitro</italic>.</td>
<td align="left" colspan="1" rowspan="1">21</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ovarian Carcinoma</td>
<td align="left" colspan="1" rowspan="1">Loss of TUSC3 (NM)</td>
<td align="left" colspan="1" rowspan="1">Expression of N33 has an impact on survival and tumour grade</td>
<td align="left" colspan="1" rowspan="1">31</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Oral squamous cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">Homozygous deletions</td>
<td align="left" colspan="1" rowspan="1">Loss of TUSC3 gene may serve as a good indicator of malignancy.</td>
<td align="left" colspan="1" rowspan="1">32</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Larynx and pharynx carcinomas</td>
<td align="left" colspan="1" rowspan="1">NM</td>
<td align="left" colspan="1" rowspan="1">Loss of TUSC3 was correlated with positive lymph node as well as a worse impact on larynx–pharynx carcinoma survival</td>
<td align="left" colspan="1" rowspan="1">33</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pancreatic adenocarcinoma</td>
<td align="left" colspan="1" rowspan="1">Heterozygous deletion</td>
<td align="left" colspan="1" rowspan="1">NM</td>
<td align="left" colspan="1" rowspan="1">42</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Primary breast tumour</td>
<td align="left" colspan="1" rowspan="1">Copy number loss within 12.7 Mb‐19.1 Mb in 8p22</td>
<td align="left" colspan="1" rowspan="1">NM</td>
<td align="left" colspan="1" rowspan="1">46</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Non‐small cell lung cancer</td>
<td align="left" colspan="1" rowspan="1">Alternative splicing</td>
<td align="left" colspan="1" rowspan="1">NM</td>
<td align="left" colspan="1" rowspan="1">51</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="jcmm13128-note-0001">
<p>
<italic>NS</italic>‐ARMR, <italic>Nonsyndromic autosomal recessive</italic> mental retardation; NM, no mention.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="jcmm13128-sec-0010">
<title>Epigenetics alterations of TUSC3</title>
<p>Silencing of TUSC3 expression can also occur by CpG methylation within the promoter. This mode of TUSC3 expression silencing is a frequent occurrence in cancer cells. DNA methylation regulates gene expression by influencing the chromatin structure and the accessibility of DNA, which are among the most common molecular alterations in human cancers and other diseases <xref ref-type="ref" rid="jcmm13128-bib-0051">51</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0052">52</xref> .</p>
<p>Aberrant hypermethylation of CpG islands in tumour suppressor genes can result in their silencing in cancer, while hypomethylation can lead to increased oncogene expression <xref ref-type="ref" rid="jcmm13128-bib-0053">53</xref>, <xref ref-type="ref" rid="jcmm13128-bib-0054">54</xref>. Local hypermethylation (at the promoter CpG island) has been well established for the inactivation of tumour suppressor genes and has attracted attention in the scientific community <xref ref-type="ref" rid="jcmm13128-bib-0055">55</xref>.</p>
<p>TUSC3 is a defined tumour suppressor gene and methylation usually occurs in its CPG island promoters. Reduction of TUSC3 gene expression in prostate cancer may be because of its methylation <xref ref-type="ref" rid="jcmm13128-bib-0010">10</xref>, and some of these methylation changes may initiate in subpopulations of normal cells as a function of aeging and progressively increase during carcinogenesis <xref ref-type="ref" rid="jcmm13128-bib-0056">56</xref>. In colon cancer, it was found that TUSC3 reduced and showed a pattern of age‐related methylation <xref ref-type="ref" rid="jcmm13128-bib-0056">56</xref>. Another research by Pils <xref ref-type="ref" rid="jcmm13128-bib-0006">6</xref> showed that TUSC3 expression decreased significantly because of promoter methylation in malignant ovarian tumours when compared with benign controls. Furthermore, TUSC3 promoter methylation showed an association with pre‐eclampsia <xref ref-type="ref" rid="jcmm13128-bib-0057">57</xref>. The TUSC3 methylation patterns are illustrated in Table <xref ref-type="table-wrap" rid="jcmm13128-tbl-0002">2</xref>.</p>
<table-wrap id="jcmm13128-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>The methylation patterns found in the TUSC3 gene</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Diseases</th>
<th align="left" colspan="1" rowspan="1" valign="top">Methylation patterns (site)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Clinical significance</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Prostate cancer cell lines, liver cancer cell lines, lung cancer cell lines, colorectal cancer cell lines</td>
<td align="left" colspan="1" rowspan="1">Exon 1 CpG islands</td>
<td align="left" colspan="1" rowspan="1">NM</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm13128-bib-0001">1</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gastric cancer</td>
<td align="left" colspan="1" rowspan="1">NM</td>
<td align="left" colspan="1" rowspan="1">TUSC3 methylation level was higher in the cases than in the healthy controls, but the difference was not significant</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm13128-bib-0031">31</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ulcerative colitis</td>
<td align="left" colspan="1" rowspan="1">The promoter CpG islands</td>
<td align="left" colspan="1" rowspan="1">TUSC3 methylation may not be associated with colorectal carcinogenesis in ulcerative colitis</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm13128-bib-0053">53</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">Promoter methylation</td>
<td align="left" colspan="1" rowspan="1">The methylation state of TUSC3 may be associated with worse survival in African American CBCS</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm13128-bib-0055">55</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Colorectal carcinogenesis</td>
<td align="left" colspan="1" rowspan="1">Promoter CpG islands</td>
<td align="left" colspan="1" rowspan="1">TUSC3 expression displayed no tumour associated changes</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm13128-bib-0010">10</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ovarian cancer</td>
<td align="left" colspan="1" rowspan="1">Promoter methylation</td>
<td align="left" colspan="1" rowspan="1">TUSC3 Promoter Methylation Predicts Survival in Patients With Ovarian Cancer</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm13128-bib-0057">57</xref>
</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In a word, further exploration of the causes of TUSC3 dysfunction, including genetics changes and epigenetic alterations, will promote an increased understanding of the causes of TUSC3‐dysfunction‐related diseases.</p>
</sec>
</sec>
<sec id="jcmm13128-sec-0011">
<title>Concluding remarks</title>
<p>Since its first identification in 1996, TUSC3 has become more and more involved in the researches of human diseases. Defects in the TUSC3 gene have been identified in individuals with non‐syndromic autosomal recessive intellectual disability in different nations. Recently, researchers recognized it as a tumour suppressor gene that is negatively related to the malignant transformation of cells. Owing to its functional importance in the process of protein maturity, the abnormal expression of TUSC3 may be the critical cause of relative diseases, such as ARMR, oral squamous cell carcinoma, ovarian cancer, <italic>et al</italic>. It is believed that TUSC3 may be used in the future as a helpful biomarker and as a therapeutic target in the diagnosis and therapy of ARMR and related cancers.</p>
<p>Regarding the various possibilities for the therapeutic targetting of the TUSC3 protein in diseases, researches on drug discovery to reinstate TUSC3 function in diseaseswill mainly focus on three avenues: (1)TUSC3 gene therapy, for example, recombinant Ad‐TUSC3 gene therapy, (2) targetting the TUSC3interactive proteins, inparticular negative regulators of TUSC3, and (3) targetting destabilized oncogenic TUSC3 mutants, that is to design mutant‐specific TUSC3 rescuedrugs. However, many structural aspects of TUSC3's function have remained elusive, such as the details of TUSC3's interactive proteins and the exact knowledge of TUSC3 mutations in diseases. TUSC3 targetting therapy has a long way to go.</p>
</sec>
<sec id="jcmm13128-sec-0013">
<title>Conflict of interest</title>
<p>The authors declare that we have no conflict of interest.</p>
</sec>
</body>
<back>
<ack id="jcmm13128-sec-0012">
<title>Acknowledgements</title>
<p>This work was supported by grants from the Medical and Health Science and Technology Development Plan of Shandong Province (2015WSB04012, 2015WS0213), grants from the Natural Science Foundation of Shandong Province (ZR2011HQ010, ZR2016HQ50, ZR2015HM077), and the National Natural Science Foundation of China (No. 30901712).</p>
</ack>
<ref-list content-type="cited-references" id="jcmm13128-bibl-0001">
<title>References</title>
<ref id="jcmm13128-bib-0001">
<label>1</label>
<mixed-citation id="jcmm13128-cit-0001" publication-type="journal">
<string-name>
<surname>MacGrogan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Levy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bova</surname>
<given-names>GS</given-names>
</string-name>, <italic>et al</italic>
<article-title>Structure and methylation‐associated silencing of a gene within a homozygously deleted region of humanchromosome band 8p22</article-title>. <source/>Genomics. <year>1996</year>; <volume>35</volume>: <fpage>55</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">8661104</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0002">
<label>2</label>
<mixed-citation id="jcmm13128-cit-0002" publication-type="journal">
<string-name>
<surname>Zhou</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Clapham</surname>
<given-names>DE</given-names>
</string-name>. <article-title>Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonicdevelopment</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2009</year>; <volume>106</volume>: <fpage>15750</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">19717468</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0003">
<label>3</label>
<mixed-citation id="jcmm13128-cit-0003" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>LX</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>M</given-names>
</string-name>, <italic>et al</italic>
<article-title>Association of TUSC3 gene polymorphisms with non‐syndromic mental retardation based on nuclear families in the Qinba mountain area of China</article-title>. <source/>Genet Mol Res. <year>2015</year>; <volume>14</volume>: <fpage>5022</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">25966277</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0004">
<label>4</label>
<mixed-citation id="jcmm13128-cit-0004" publication-type="journal">
<string-name>
<surname>Garshasbi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hadavi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Habibi</surname>
<given-names>H</given-names>
</string-name>, <italic>et al</italic>
<article-title>A defect in the TUSC3 gene is associated with autosomal recessive mental retardation</article-title>. <source/>Am J Hum Genet. <year>2008</year>; <volume>82</volume>: <fpage>1158</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">18452889</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0005">
<label>5</label>
<mixed-citation id="jcmm13128-cit-0005" publication-type="journal">
<string-name>
<surname>Garshasbi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kahrizi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hosseini</surname>
<given-names>M</given-names>
</string-name>, <italic>et al</italic>
<article-title>A novel nonsense mutation in TUSC3 is responsible for non‐syndromic autosomal recessive mental retardationin a consanguineous Iranian family</article-title>. <source/>Am J Med Genet A. <year>2011</year>; <volume>155A</volume>: <fpage>1976</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">21739581</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0006">
<label>6</label>
<mixed-citation id="jcmm13128-cit-0006" publication-type="journal">
<string-name>
<surname>Pils</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Horak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Vanhara</surname>
<given-names>P</given-names>
</string-name>, <italic>et al</italic>
<article-title>Methylation status of TUSC3 is a prognostic factor in ovarian cancer</article-title>. <source/>Cancer. <year>2013</year>; <volume>119</volume>: <fpage>946</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">23096450</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0007">
<label>7</label>
<mixed-citation id="jcmm13128-cit-0007" publication-type="journal">
<string-name>
<surname>Molinari</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Foulquier</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tarpey</surname>
<given-names>PS</given-names>
</string-name>, <italic>et al</italic>
<article-title>Oligosaccharyl transferase subunit mutations in non syndromic mental retardation</article-title>. <source/>Am J Hum Genet. <year>2008</year>; <volume>82</volume>: <fpage>1150</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">18455129</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0008">
<label>8</label>
<mixed-citation id="jcmm13128-cit-0008" publication-type="journal">
<string-name>
<surname>Mohorko</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Owen</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Malojčić</surname>
<given-names>G</given-names>
</string-name>, <italic>et al</italic>
<article-title>Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N‐glycosylation</article-title>. <source/>Structure. <year>2014</year>; <volume>22</volume>: <fpage>590</fpage>–<lpage>601</lpage>.<pub-id pub-id-type="pmid">24685145</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0009">
<label>9</label>
<mixed-citation id="jcmm13128-cit-0009" publication-type="journal">
<string-name>
<surname>Jamaluddin</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Bailey</surname>
<given-names>UM</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>NY</given-names>
</string-name>, <italic>et al</italic>
<article-title>Polypeptide binding specificities of Saccharomyces cerevisiae oligosaccharyl‐transferase accessory proteins Ost3p and Ost6p</article-title>. <source/>Protein Sci. <year>2011</year>; <volume>20</volume>: <fpage>849</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">21384453</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0010">
<label>10</label>
<mixed-citation id="jcmm13128-cit-0010" publication-type="journal">
<string-name>
<surname>Horak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tomasich</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Vaňhara</surname>
<given-names>P</given-names>
</string-name>, <italic>et al</italic>
<article-title>TUSC3 loss alters the ER stressresponse and accelerates prostate cancer growth <italic>in vivo</italic>
</article-title>. <source/>Sci Rep. <year>2014</year>; <volume>4</volume>: <fpage>3739</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">24435307</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0011">
<label>11</label>
<mixed-citation id="jcmm13128-cit-0011" publication-type="journal">
<string-name>
<surname>Kratochvílová</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Horak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ešner</surname>
<given-names>M</given-names>
</string-name>, <italic>et al</italic>
<article-title>Tumor suppressor candidate 3 (TUSC3) prevents the epithelial‐to‐mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells</article-title>. <source/>Int J Cancer. <year>2015</year>; <volume>137</volume>: <fpage>1330</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">25735931</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0012">
<label>12</label>
<mixed-citation id="jcmm13128-cit-0012" publication-type="journal">
<string-name>
<surname>Bova</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>MacGrogan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Levy</surname>
<given-names>A</given-names>
</string-name>, <italic>et al</italic>
<article-title>Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer</article-title>. <source/>Genomics. <year>1996</year>; <volume>35</volume>: <fpage>46</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">8661103</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0013">
<label>13</label>
<mixed-citation id="jcmm13128-cit-0013" publication-type="journal">
<string-name>
<surname>Khan</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Rafiq</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Noor</surname>
<given-names>A</given-names>
</string-name>, <italic>et al</italic>
<article-title>A novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family with autosomal recessive nonsyndromic intellectual disability</article-title>. <source/>BMC Med Genet. <year>2011</year>; <volume>22</volume>: <fpage>56</fpage>–<lpage>61</lpage>.</mixed-citation>
</ref>
<ref id="jcmm13128-bib-0014">
<label>14</label>
<mixed-citation id="jcmm13128-cit-0014" publication-type="journal">
<string-name>
<surname>Nusbaum</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mikkelsen</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>Zody</surname>
<given-names>MC</given-names>
</string-name>, <italic>et al</italic>
<article-title>DNA sequence and analysis of human chromosome 8</article-title>. <source/>Nature. <year>2006</year>; <volume>439</volume>: <fpage>331</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">16421571</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0015">
<label>15</label>
<mixed-citation id="jcmm13128-cit-0015" publication-type="journal">
<string-name>
<surname>Wong</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>LeeJM</surname>
<given-names>Ching YP</given-names>
</string-name>, <italic>et al</italic>
<article-title>Genetic and epigenetic alterations of DLC‐1 gene in hepatocellular carcinoma</article-title>. <source/>Cancer Res. <year>2003</year>; <volume>63</volume>: <fpage>7646</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">14633684</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0016">
<label>16</label>
<mixed-citation id="jcmm13128-cit-0016" publication-type="journal">
<string-name>
<surname>Mohorko</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Glockshuber</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Aebi</surname>
<given-names>M</given-names>
</string-name>. <article-title>Oligosaccharyltransferase: the central enzyme of N‐linked protein glycosylation</article-title>. <source/>J Inherit Metab Dis. <year>2011</year>; <volume>34</volume>: <fpage>869</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">21614585</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0017">
<label>17</label>
<mixed-citation id="jcmm13128-cit-0017" publication-type="journal">
<string-name>
<surname>Vandewynckel</surname>
<given-names>YP</given-names>
</string-name>, <string-name>
<surname>Laukens</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Geerts</surname>
<given-names>A</given-names>
</string-name>, <italic>et al</italic>
<article-title>The paradox of the unfolded protein response in cancer</article-title>. <source/>Anticancer Res. <year>2013</year>; <volume>33</volume>: <fpage>4683</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">24222102</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0018">
<label>18</label>
<mixed-citation id="jcmm13128-cit-0018" publication-type="journal">
<string-name>
<surname>Breitling</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Aebi</surname>
<given-names>M</given-names>
</string-name>. <article-title>N‐linked protein glycosylation in the endoplasmic reticulum</article-title>. <source/>Cold Spring Harb Perspect Biol. <year>2013</year>; <volume>5</volume>: <fpage>a013359</fpage>.<pub-id pub-id-type="pmid">23751184</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0019">
<label>19</label>
<mixed-citation id="jcmm13128-cit-0019" publication-type="journal">
<string-name>
<surname>Das</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Heath</surname>
<given-names>EC</given-names>
</string-name>. <article-title>Dolichyldiphosphoryl oligosaccharide‐protein oligosaccharyl transferase; solubilization, purification, and properties</article-title>. <source/>Proc Natl Acad Sci. <year>1980</year>; <volume>77</volume>: <fpage>3811</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">6933437</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0020">
<label>20</label>
<mixed-citation id="jcmm13128-cit-0020" publication-type="journal">
<string-name>
<surname>Kelleher</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Karaoglu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mandon</surname>
<given-names>EC</given-names>
</string-name>, <italic>et al</italic>
<article-title>Oligosaccharyl transferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties</article-title>. <source/>Mol Cell. <year>2003</year>; <volume>12</volume>: <fpage>101</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">12887896</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0021">
<label>21</label>
<mixed-citation id="jcmm13128-cit-0021" publication-type="journal">
<string-name>
<surname>Vaňhara</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Horak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Pils</surname>
<given-names>D</given-names>
</string-name>, <italic>et al</italic>
<article-title>Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancercells</article-title>. <source/>Int J Oncol. <year>2013</year>; <volume>42</volume>: <fpage>1383</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">23404293</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0022">
<label>22</label>
<mixed-citation id="jcmm13128-cit-0022" publication-type="journal">
<string-name>
<surname>Glancy</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Barnicoat</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vijeratnam</surname>
<given-names>R</given-names>
</string-name>, <italic>et al</italic>
<article-title>Transmitted duplication of 8p23.1‐8p23.2 associated with speech delay, autism and learning difficulties</article-title>. <source/>Eur J Hum Genet. <year>2009</year>; <volume>14</volume>: <fpage>37</fpage>–<lpage>43</lpage>.</mixed-citation>
</ref>
<ref id="jcmm13128-bib-0023">
<label>23</label>
<mixed-citation id="jcmm13128-cit-0023" publication-type="journal">
<string-name>
<surname>Tabarés‐Seisdedos</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</string-name>. <article-title>Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer</article-title>. <source/>Mol Psychiatry. <year>2009</year>; <volume>14</volume>: <fpage>563</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">19204725</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0024">
<label>24</label>
<mixed-citation id="jcmm13128-cit-0024" publication-type="journal">
<string-name>
<surname>Khalid</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Asano</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hosaka</surname>
<given-names>YZ</given-names>
</string-name>, <italic>et al</italic>
<article-title>Tumor suppressor candidate TUSC3 expression during rat testis maturation</article-title>. <source/>Biosci Biotechnol Biochem. <year>2013</year>; <volume>77</volume>: <fpage>2019</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">24096664</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0025">
<label>25</label>
<mixed-citation id="jcmm13128-cit-0025" publication-type="journal">
<string-name>
<surname>Slutsky</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Abumaria</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>LJ</given-names>
</string-name>, <italic>et al</italic>
<article-title>Enhancement of learning and memory by elevating brain magnesium</article-title>. <source/>Neuron. <year>2010</year>; <volume>65</volume>: <fpage>165</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">20152124</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0026">
<label>26</label>
<mixed-citation id="jcmm13128-cit-0026" publication-type="journal">
<string-name>
<surname>Rual</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Venkatesan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hao</surname>
<given-names>T</given-names>
</string-name>, <italic>et al</italic>
<article-title>Towards a proteome‐scale map of the human protein‐protein interaction network</article-title>. <source/>Nature. <year>2005</year>; <volume>437</volume>: <fpage>1173</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">16189514</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0027">
<label>27</label>
<mixed-citation id="jcmm13128-cit-0027" publication-type="journal">
<string-name>
<surname>Munton</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Vizi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mansuy</surname>
<given-names>IM</given-names>
</string-name>. <article-title>The role of protein phosphatase‐1 in the modulation of synaptic and structural plasticity</article-title>. <source/>FEBS Lett. <year>2004</year>; <volume>567</volume>: <fpage>121</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">15165904</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0028">
<label>28</label>
<mixed-citation id="jcmm13128-cit-0028" publication-type="journal">
<string-name>
<surname>Chandra</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Sengupta</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Goswami</surname>
<given-names>H</given-names>
</string-name>, <italic>et al</italic>
<article-title>Effects of dietary magnesium on testicular histology, steroidogenesis, spermatogenesis and oxidative stress markers in adult rats</article-title>. <source/>Indian J Exp Biol. <year>2013</year>; <volume>51</volume>: <fpage>37</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">23441478</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0029">
<label>29</label>
<mixed-citation id="jcmm13128-cit-0029" publication-type="journal">
<string-name>
<surname>Levy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dang</surname>
<given-names>UC</given-names>
</string-name>, <string-name>
<surname>Bookstein</surname>
<given-names>R</given-names>
</string-name>. <article-title>High‐density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8p</article-title>. <source/>Genes Chromosomes Cancer. <year>1999</year>; <volume>24</volume>: <fpage>42</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">9892107</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0030">
<label>30</label>
<mixed-citation id="jcmm13128-cit-0030" publication-type="journal">
<string-name>
<surname>Pils</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Horak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gleiss</surname>
<given-names>A</given-names>
</string-name>, <italic>et al</italic>
<article-title>Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival</article-title>. <source/>Cancer. <year>2005</year>; <volume>104</volume>: <fpage>2417</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">16270321</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0031">
<label>31</label>
<mixed-citation id="jcmm13128-cit-0031" publication-type="journal">
<string-name>
<surname>Yuasa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nagasaki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Oze</surname>
<given-names>I</given-names>
</string-name>, <italic>et al</italic>
<article-title>Insulin‐like growth factor 2 hypomethylation of blood leukocyte DNA is associated with gastric cancer risk</article-title>. <source/>Int J Cancer. <year>2012</year>; <volume>131</volume>: <fpage>2596</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">22447362</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0032">
<label>32</label>
<mixed-citation id="jcmm13128-cit-0032" publication-type="journal">
<string-name>
<surname>Ribeiro</surname>
<given-names>IP</given-names>
</string-name>, <string-name>
<surname>Marques</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Caramelo</surname>
<given-names>F</given-names>
</string-name>, <italic>et al</italic>
<article-title>Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management</article-title>. <source/>Cell Oncol (Dordr). <year>2014</year>; <volume>37</volume>: <fpage>29</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">24353162</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0033">
<label>33</label>
<mixed-citation id="jcmm13128-cit-0033" publication-type="journal">
<string-name>
<surname>Guervós</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Marcos</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Hermsen</surname>
<given-names>M</given-names>
</string-name>, <italic>et al</italic>
<article-title>Deletions of N33, STK11 and TP53 are involved in the development of lymph node metastasis in larynx andpharynx carcinomas</article-title>. <source/>Cell Oncol. <year>2007</year>; <volume>29</volume>: <fpage>327</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">17641416</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0034">
<label>34</label>
<mixed-citation id="jcmm13128-cit-0034" publication-type="journal">
<string-name>
<surname>Yan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Lennarz</surname>
<given-names>WJ</given-names>
</string-name>. <article-title>Oligosaccharyl transferase: a complex multisubunit enzyme of the endoplasmic reticulum</article-title>. <source/>Biochem Biophys Res Commun. <year>1999</year>; <volume>266</volume>: <fpage>684</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">10603306</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0035">
<label>35</label>
<mixed-citation id="jcmm13128-cit-0035" publication-type="journal">
<string-name>
<surname>Hauselmann</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Borsig</surname>
<given-names>L</given-names>
</string-name>. <article-title>Altered tumor‐cell glycosylation promotes metastasis</article-title>. <source/>Front 13 Oncol. <year>2014</year>; <volume>4</volume>: <fpage>00028</fpage>.</mixed-citation>
</ref>
<ref id="jcmm13128-bib-0036">
<label>36</label>
<mixed-citation id="jcmm13128-cit-0036" publication-type="journal">
<string-name>
<surname>Chehadeh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bonnet</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Callier</surname>
<given-names>P</given-names>
</string-name>, <italic>et al</italic>
<article-title>Homozygous truncating intragenic duplication in TUSC3 responsible for rare autosomal recessive nonsyndromic intellectual disability with no clinical or biochemical metabolic markers</article-title>. <source/>JIMD Rep. <year>2015</year>; <volume>20</volume>: <fpage>45</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">25626710</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0037">
<label>37</label>
<mixed-citation id="jcmm13128-cit-0037" publication-type="journal">
<string-name>
<surname>Haltiwanger</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Lowe</surname>
<given-names>JB</given-names>
</string-name>. <article-title>Role of glycosylation in development</article-title>. <source/>Annu Rev Biochem. <year>2004</year>; <volume>73</volume>: <fpage>491</fpage>–<lpage>537</lpage>.<pub-id pub-id-type="pmid">15189151</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0038">
<label>38</label>
<mixed-citation id="jcmm13128-cit-0038" publication-type="journal">
<string-name>
<surname>Fang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>S</given-names>
</string-name>, <italic>et al</italic>
<article-title>The ER UDPase ENTPD5 promotes protein N‐glycosylation, the Warburg effect, and proliferation in the PTEN pathway</article-title>. <source/>Cell. <year>2010</year>; <volume>143</volume>: <fpage>711</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">21074248</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0039">
<label>39</label>
<mixed-citation id="jcmm13128-cit-0039" publication-type="journal">
<string-name>
<surname>Bashyam</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Bair</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YH</given-names>
</string-name>, <italic>et al</italic>
<article-title>Array‐based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer</article-title>. <source/>Neoplasia. <year>2005</year>; <volume>7</volume>: <fpage>556</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">16036106</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0040">
<label>40</label>
<mixed-citation id="jcmm13128-cit-0040" publication-type="journal">
<string-name>
<surname>Bova</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Bussemakers</surname>
<given-names>MJ</given-names>
</string-name>, <italic>et al</italic>
<article-title>Homozygous deletion and frequent allelic loss of chromosome</article-title>. <source/>Cancer Res. <year>1993</year>; <volume>53</volume>: <fpage>3869</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">7689419</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0041">
<label>41</label>
<mixed-citation id="jcmm13128-cit-0041" publication-type="journal">
<string-name>
<surname>Birnbaum</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Adélaïde</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mamessier</surname>
<given-names>E</given-names>
</string-name>, <italic>et al</italic>
<article-title>Genome profiling of pancreatic adenocarcinoma</article-title>. <source/>Genes Chromosomes Cancer. <year>2011</year>; <volume>50</volume>: <fpage>456</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">21412932</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0042">
<label>42</label>
<mixed-citation id="jcmm13128-cit-0042" publication-type="journal">
<string-name>
<surname>Loddo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Parisi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Doccini</surname>
<given-names>V</given-names>
</string-name>, <italic>et al</italic>
<article-title>Homozygous deletion in TUSC3 causing syndromic intellectual disability: a new patient</article-title>. <source/>Am J Med Genet A. <year>2013</year>; <volume>161A</volume>: <fpage>2084</fpage>–<lpage>208</lpage>.<pub-id pub-id-type="pmid">23825019</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0043">
<label>43</label>
<mixed-citation id="jcmm13128-cit-0043" publication-type="journal">
<string-name>
<surname>Ghadami</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mohammadi</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Malbin</surname>
<given-names>J</given-names>
</string-name>, <italic>et al</italic>
<article-title>Frequencies of six (Five Novel) STR markers linked to TUSC3 (MRT7) or NSUN2 (MRT5) genes used for homozygosity mapping of recessive intellectual disability</article-title>. <source/>Clin Lab. <year>2015</year>; <volume>61</volume>: <fpage>925</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">26427135</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0044">
<label>44</label>
<mixed-citation id="jcmm13128-cit-0044" publication-type="journal">
<string-name>
<surname>Sleptsov</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Nazarenko</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Lebedev</surname>
<given-names>IN</given-names>
</string-name>, <italic>et al</italic>
<article-title>Somatic genome variations in vascular tissues and peripheral blood leukocytes in patients with atherosclerosis</article-title>. <source/>Genetika. <year>2014</year>; <volume>50</volume>: <fpage>986</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">25731028</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0045">
<label>45</label>
<mixed-citation id="jcmm13128-cit-0045" publication-type="journal">
<string-name>
<surname>Cooke</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Pole</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Chin</surname>
<given-names>SF</given-names>
</string-name>, <italic>et al</italic>
<article-title>High‐resolution array CGH clarifies events occurring on 8p in carcinogenesis</article-title>. <source/>BMC Cancer. <year>2008</year>; <volume>8</volume>: <fpage>288</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">18840272</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0046">
<label>46</label>
<mixed-citation id="jcmm13128-cit-0046" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hadley</surname>
<given-names>D</given-names>
</string-name>, <italic>et al</italic>
<article-title>An integrated hidden Markov model designed for high‐resolution copy number variation detection in whole‐genome SNP genotyping data</article-title>. <source/>Genome Res. <year>2007</year>; <volume>17</volume>: <fpage>1665</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">17921354</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0047">
<label>47</label>
<mixed-citation id="jcmm13128-cit-0047" publication-type="journal">
<string-name>
<surname>Redon</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ishikawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fitch</surname>
<given-names>KR</given-names>
</string-name>, <italic>et al</italic>
<article-title>Global variation in copy number in the human genome</article-title>. <source/>Nature. <year>2006</year>; <volume>444</volume>: <fpage>444</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">17122850</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0048">
<label>48</label>
<mixed-citation id="jcmm13128-cit-0048" publication-type="journal">
<string-name>
<surname>McCarroll</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Hadnott</surname>
<given-names>TN</given-names>
</string-name>, <string-name>
<surname>Perry</surname>
<given-names>GH</given-names>
</string-name>, <italic>et al</italic>
<article-title>Common deletion polymorphisms in the human genome</article-title>. <source/>Nat Genet. <year>2006</year>; <volume>38</volume>: <fpage>86</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">16468122</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0049">
<label>49</label>
<mixed-citation id="jcmm13128-cit-0049" publication-type="journal">
<string-name>
<surname>Conrad</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Andrews</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>NP</given-names>
</string-name>, <italic>et al</italic>
<article-title>A high‐resolution survey of deletion polymorphism in the human genome</article-title>. <source/>Nat Genet. <year>2006</year>; <volume>38</volume>: <fpage>75</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">16327808</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0050">
<label>50</label>
<mixed-citation id="jcmm13128-cit-0050" publication-type="journal">
<string-name>
<surname>Baty</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Klingbiel</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zappa</surname>
<given-names>F</given-names>
</string-name>, <italic>et al</italic>
<article-title>High‐throughput alternative splicing detection using dually constrained correspondence analysis (DCCA)</article-title>. <source/>J Biomed Inform. <year>2015</year>; <volume>58</volume>: <fpage>175</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">26483173</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0051">
<label>51</label>
<mixed-citation id="jcmm13128-cit-0051" publication-type="journal">
<string-name>
<surname>Jones</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Baylin</surname>
<given-names>SB</given-names>
</string-name>. <article-title>The fundamental role of epigenetic events in cancer</article-title>. <source/>Nat Rev Genet. <year>2002</year>; <volume>3</volume>: <fpage>415</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">12042769</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0052">
<label>52</label>
<mixed-citation id="jcmm13128-cit-0052" publication-type="journal">
<string-name>
<surname>Arasaradnam</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Khoo</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bradburn</surname>
<given-names>M</given-names>
</string-name>, <italic>et al</italic>
<article-title>DNA methylation of ESR‐1 and N‐33 in colorectal mucosa of patients with ulcerative colitis (UC)</article-title>. <source/>Epigenetics. <year>2010</year>; <volume>5</volume>: <fpage>422</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">20505342</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0053">
<label>53</label>
<mixed-citation id="jcmm13128-cit-0053" publication-type="journal">
<string-name>
<surname>Kamalakaran</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Varadan</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Giercksky Russnes</surname>
<given-names>HE</given-names>
</string-name>, <italic>et al</italic>
<article-title>DNA methylation patterns in luminal breast cancers differ from non‐luminal subtypes and can identify relapse risk independent of other clinical variables</article-title>. <source/>Mol Oncol. <year>2011</year>; <volume>5</volume>: <fpage>77</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">21169070</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0054">
<label>54</label>
<mixed-citation id="jcmm13128-cit-0054" publication-type="journal">
<string-name>
<surname>Conway</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Edmiston</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Tse</surname>
<given-names>CK</given-names>
</string-name>, <italic>et al</italic>
<article-title>Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study</article-title>. <source/>Cancer Epidemiol Biomarkers Prev. <year>2015</year>; <volume>24</volume>: <fpage>921</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">25809865</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0055">
<label>55</label>
<mixed-citation id="jcmm13128-cit-0055" publication-type="journal">
<string-name>
<surname>Xu</surname>
<given-names>XL</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>HY</given-names>
</string-name>, <italic>et al</italic>
<article-title>Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis</article-title>. <source/>World J Gastroenterol. <year>2004</year>; <volume>10</volume>: <fpage>3441</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">15526363</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0056">
<label>56</label>
<mixed-citation id="jcmm13128-cit-0056" publication-type="journal">
<string-name>
<surname>Ahu ja</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Issa</surname>
<given-names>JP</given-names>
</string-name>. <article-title>Aging, methylation and cancer</article-title>. <source/>Histol Histopathol. <year>2000</year>; <volume>15</volume>: <fpage>835</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">10963127</pub-id></mixed-citation>
</ref>
<ref id="jcmm13128-bib-0057">
<label>57</label>
<mixed-citation id="jcmm13128-cit-0057" publication-type="journal">
<string-name>
<surname>Yuen</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Avila</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Peñaherrera</surname>
<given-names>MS</given-names>
</string-name>, <italic>et al</italic>
<article-title>Human placental‐specific epipolymorphism and its association with adverse pregnancy outcomes</article-title>. <source/>PLoS One. <year>2009</year>; <volume>4</volume>: <fpage>e7389</fpage>.<pub-id pub-id-type="pmid">19838307</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>